What's new

EMEA-002474-PIP02-18-M02

EMEA-002474-PIP02-18-M02

Jun 16, 2025 - 13:45
 0
EMEA-002474-PIP02-18-M02
EMEA-002474-PIP02-18-M02
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Zynlonta, Loncastuxim...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Orladeyo, Berotralsta...

Related Posts

Orphan designation: Adeno-associated virus serotype rh79 containing the human OTC gene, adeno-associated virus serotype rh79 encoding a meganuclease for targeted editing of the human PCSK9 gene Treatment of ornithine transcarbamylase deficiency, 09/12/2022 Positive

Orphan designation: Adeno-associated virus serotype rh7...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Ovitrelle, choriogonadotropin alfa, Date of authorisation: 02/02/2001, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0